Article info

Download PDFPDF

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
  1. Correspondence to Professor Nicoline Hoogerbrugge, 849 Human Genetics, Radboud University Nijmegen Medical Centre, Postbox 9101, 6500 HB Nijmegen, The Netherlands; n.hoogerbrugge{at}antrg.umcn.nl
View Full Text

Citation

van der Post RS, Kiemeney LA, Ligtenberg MJL, et al
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers

Publication history

  • Received January 11, 2010
  • Revised February 9, 2010
  • Accepted February 11, 2010
  • First published June 30, 2010.
Online issue publication 
June 30, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.